Delisting of Securities of Better Therapeutics, Inc.; Tritium DCFC Limited; Arcimoto, Inc.; Next.e.GO N.V.; Acutus Medical, Inc.; and NeuBase Therapeutics, Inc. From The Nasdaq Stock Market
NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Better Therapeutics, Inc. Better Therapeutics, Inc.'s securities were suspended on March 18,
Express News | NeuBase Therapeutics - Expects Trading in Co's Common Stock Will Be Suspended Upon Opening of Business on May 13
Express News | NeuBase Therapeutics Inc - on May 2, Nasdaq Notified Company That It Has Not Regained Compliance With Minimum Bid Price Requirement
NeuBase Therapeutics Announces Receipt of Notice From Nasdaq
PITTSBURGH, April 05, 2024 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (NASDAQ:NBSE) ("NeuBase" or the "Company") today reported that it received a notice (the "Notice) on April 4, 2024 from the Listing
Why Neubase Therapeutics (NBSE) Shares Are Nosediving
Neubase Therapeutics Inc (NASDAQ:NBSE) shares are trading lower by 53% to $0.47 during Tuesday's session after the company on Monday announced it is holding a Special Meeting of Stockholders on May 13
VERI, CHEK and CZOO Among Mid-day Movers
NeuBase Therapeutics, ABVC BioPharma, Stoke Therapeutics Among Healthcare Movers
Wall Street Set to Open Modestly Higher Tuesday Ahead Consumer Confidence Reading
US stocks looked set to open modestly higher Tuesday as investors parsed durable goods and home price data and looked ahead to a key consumer confidence gauge. Dow Jones Industrial Average futures wer
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersStoke Therapeutics (NASDAQ:STOK) stock increased by 80.2% to $11.71 during Tuesday's pre-market session. The market value of their outstanding shares is at $522.8 million. As per the press rele
US Futures Trend Higher Ahead of Durable Goods, House Prices, Consumer Confidence Readings
US stock futures were trending higher in Tuesday's premarket session ahead of durable goods and house price data, alongside the latest consumer confidence gauge, due later in the morning. The Dow Jone
Top Premarket Decliners
NeuBase Therapeutics (NBSE) stock fell 58% in recent Tuesday premarket activity, extending Monday's decline. AppTech Payments (APCX) shares tumbled 40% a day after saying it planned to sell its common
GOEV, NBSE and FLGC Among Pre-market Losers
Myotonic Dystrophy Drug Pipeline Landscape Report 2024 Featuring AMO Pharma, Harmony Biosciences, Entrada Therapeutics, Arrowhead Pharmaceuticals, Arthex Biotech, NeuBase Therapeutics, and Enzerna
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersZyVersa Therapeutics (NASDAQ:ZVSA) stock increased by 44.8% to $1.16 during Monday's pre-market session. The market value of their outstanding shares is at $5.3 million. Agiliti (NYSE:AGTI) sha
NeuBase Therapeutics (NBSE) Faces Uncertain Future Despite After-Hours Surge
NeuBase Therapeutics (NASDAQ: NBSE), a notable player in genetic neurological disorder treatments, experienced a bumpy ride in the stock market last Friday. Initially taking a nosedive by 7.51%, the stock made a dramatic rebound over the weekend, surging an astonishing 42% during after-hours trading. Such volatility left investors scratching their heads, pondering the underlying reasons ...
NeuBase Therapeutics Plans Dissolution and Asset Liquidation
Express News | Neubase Therapeutics On Feb 22, Board Determined For Company To Dissolve, Liquidate And Distribute To Stockholders Its Available Assets; Has Been Engaged In Evaluation Of Potential Strategic And Other Alternatives
NeuBase Therapeutics Strikes Definitive Warrant Agreement
Neubase Therapeutics Filed Prospectus Supplement Related To Offering Of Up To $10M Of Shares Of Common Stock
-424B3https://www.sec.gov/Archives/edgar/data/1173281/000110465923129848/tm2333795d1_424b3.htm
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersNexImmune (NASDAQ:NEXI) stock moved upwards by 343.1% to $10.99 during Friday's pre-market session. The market value of their outstanding shares is at $11.6 million. Altimmune (NASDAQ:ALT) stoc
No Data